Aprea Therapeutics (NASDAQ:APRE) just reported results for the first quarter of 2024.
- Aprea Therapeutics reported earnings per share of -67 cents. This was above the analyst estimate for EPS of -78 cents.
- The company reported revenue of $380,569.
Source: iQoncept / Shutterstock
Aprea Therapeutics (NASDAQ:APRE) just reported results for the first quarter of 2024.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/apre-stock-earnings-aprea-therapeutics-for-q1-of-2024/.
©2025 InvestorPlace Media, LLC